Genprex, Inc. (GNPX)

CIK 0001595248 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Balance Sheets
—
Condensed Balance Sheets (current Period Unaudited)
—
Condensed Consolidated Balance Sheets (current Period Unaudited)
—
Consolidated Balance Sheets
—
Consolidated Condensed Balance Sheets (current Period Unaudited)
—
Balance Sheets (P)
—
Condensed Balance Sheets (current Period Unaudited) (P)
—
Condensed Consolidated Balance Sheets (current Period Unaudited) (P)
—
Consolidated Balance Sheets (P)
—
Consolidated Condensed Balance Sheets (current Period Unaudited) (P)
—
Consolidated Condensed Statements of Operations (unaudited)
—
Consolidated Statements of Operations
Statements of Operations
Consolidated Condensed Statements of Changes In Stockholders' Equity (unaudited)
—
Consolidated Statements of Changes In Stockholders' Equity
Statements of Changes In Stockholders' Equity
Consolidated Condensed Statements of Cash Flows (unaudited)
—
Consolidated Statements of Cash Flows
Statements of Cash Flows
Notes
Award Timing Disclosure
—
Cybersecurity Risk Management and Strategy Disclosure
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Note 1
Note 10
—
Note 2
Note 3
Note 4
Note 5
Note 6
Note 7
Note 8
Note 9